References
- Adams S. S., Cobb R. Nature (London) (1958); 131: 773–774
- Anderson A. J. Biochem. Pharmacol. (1968); 17: 2253–2264
- Bangham A. D., Standish M. M., Weissmann G. J. Mol. Biol. (1965); 13: 253–259
- Barker J. L., Levitan H. Biochim. Biophys. Acta (1972); 274: 638–643
- Billingham M. E.J., Gordon A. H., Robinson B. V. Nature (New Biology) (1971); 231: 26–27
- Bongiovanni A. M., Eberlein W. R., Grumbach M. M., Van Wyk J.J., Clayton G. Proc. Soc. Exp. Biol. Med. (1954); 87: 282–287
- Boyse E. A., Old L. J., Chouroulinkov I. Methods Med. Res. (1964); 10: 39–47
- Brody J. M. J. Pharmacol. Exp. Ther. (1956); 117: 39–51
- Brown H., Willardson D. J., Samuels L. T., Tyler F. H. J. Clin. Invest. (1954); 33: 1524–1532
- Chance B., Williams G. R. J. Biol. Chem. (1955); 217: 383–407
- Chance B., Williams G. R. Advan. Enzymol. (1956); 17: 65–134
- Contessa A. R. Boll. Soc. ital. Biol. sper. (1962); 38: 1076–1078
- Englert E.Jr, Brown H., Wallach S., Simons E. L. J. Clin. Endocrinol. Metabol. (1957); 17: 1395–1406
- Famaey J.-P. Biochem. Pharmacol. (1973); 22: 2693–2705
- Famaey J.-P., Mockel J. Biochem. Pharmacol. (1973); 22: 1487–1498
- Famaey J.-P., Whitehouse M. W. Biochem. Pharmacol. (1973); 22: 2707–2717
- Famaey J.-P., Whitehouse M. W. Biochem. Pharmacol. (1975, a); 24: 1609–1615
- Famaey J.-P., Whitehouse M. W. Agents and Actions (1975, b); 5: 133–136
- Famaey J.-P., Whitehouse M. W., Dick W. C. Biochem. Pharmacol. (1975); 24: 267–275
- Hench P. S. Proc. Mayo Clin. (1933); 8: 430–436
- Hench P. S. Proc. Mayo Clin. (1938); 13: 161–167
- Hench P. S. Med. Clin. N. Amer. (1940); 24: 1209–1237
- Hill S. R., Jr., Holley H. L. Arthritis and Allied Disorders, 7th edn., J. L. Hollander. Lea & Febiger, Philadelphia (1968); 606–614
- Judah J. D., Williams-Ashman H. G. Biochem. J. (1951); 48: 33–42
- Lee M. J., Whitehouse M. W. Biochem. J. (1964); 90: 17P
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. J. Biol. Chem. (1951); 193: 265–275
- MacArthur J. N., Dawkins P. D., Smith M. J.H. J. Pharm. Pharmacol. (1971); 23: 393–398
- McLaughlin S. Nature (London) (1973); 243: 234–236
- Mielens Z. E., Drobeck H. P., Rozitis J., Jr, Sansone V. J., Jr. Toxicol. Appl. Pharmacol. (1969); 14: 293–300
- Mizushima Y., Sakai S., Yamaura M. Biochem. Pharmacol. (1970); 19: 227–234
- Pennial R., Kalnitsky G., Routh J. I. Arch. Bioch. Biophys. (1956); 64: 390–400
- Pinals R. S. Ann. Rheum. Dis. (1973); 32: 471–474
- Schlosstein L., Kippen I., Bluestone R., Whitehouse M.W., Klinenberg J. R. Ann. Rheum. Dis. (1974); 33: 308–312
- Seeman P. Pharmacol. Rev. (1972); 24: 583–655
- Smith G. M., Parsons M. E., Whitehouse M. W. J. Pharm. Pharmacol. (1964); 16: 830–831
- Stenger E. G. Arch, internal. Pharmacodyn. (1959); 120: 39–47
- Walz D. T., Di Martino M. J., Misher A. J. Pharmacol. Exp. Ther. (1971); 178: 223–231
- Weissmann G. The Interactions of Drugs and Subcellular Components in Animal Cells, P. N. Campbell. Little Brown & Co, Boston (1968); 203–217
- Whitehouse M. W. Progr. Drug Res. (1968); 8: 321–429
- Yu D. T.J., Peter J. B. Seminars Arthr. Rheum. (1974); 4: 35–52